03750nam 2200661 a 450 991077973570332120230725061529.03-11-032612-410.1515/9783110326123(CKB)2550000001097091(EBL)1215599(OCoLC)851972145(SSID)ssj0000801402(PQKBManifestationID)11440769(PQKBTitleCode)TC0000801402(PQKBWorkID)10773996(PQKB)10127491(MiAaPQ)EBC1215599(DE-B1597)211487(OCoLC)853268657(OCoLC)978682293(DE-B1597)9783110326123(Au-PeEL)EBL1215599(CaPaEBR)ebr10728641(CaONFJC)MIL503625(OCoLC)854568792(EXLCZ)99255000000109709120130709d2010 uy 0engur|n|---|||||txtccrThe ultimate constituents of the material world[electronic resource] in search of an ontology for fundamental physics /Meinard KuhlmannFrankfurt Ontos Verlag20101 online resource (291 p.)Philosophische Analyse / Philosophical analysis ;Bd. 37Description based upon print version of record.3-11-032527-6 1-299-72374-8 Includes bibliographical references. Frontmatter -- Contents -- Preface -- Part I. Ontology and Quantum Field Theory -- 1. Introduction -- 2. Philosophical Background -- 3. Ontology and Physics -- 4. History and Basic Structure of QFT -- 5. Alternative Approaches -- 6. The Ontological Significance of QFT and AQFT -- Part II. Classical Ontologies -- 7. Classical vs. Revisionary Ontologies -- 8. Particle Interpretation of QFT -- 9. Field Interpretations of QFT -- Part III. Revisionary Ontologies -- 10. Process Ontology -- 11. Trope Ontology I: The Ontological -- 12. Trope Ontology II: Properties and Things -- Part IV. The Trope Bundle Interpretation of QFT: A New Ontology for Fundamental Physics -- 13. Dispositional Trope Ontology -- Part V. Concluding Remarks -- 14. Physics and Philosophy -- 15. Summing Up -- Part VI. Appendices -- Abbreviations and Notation -- A. Special Relativity Theory: Some Notation and Required Results -- B. Ontologically Oriented Survey of Quantum Mechanics -- C. Advanced Foundational Topics in QFT -- D. Assumptions and Results of AQFT -- Bibliography -- Physics (and Mathematics) Glossary -- Philosophy Glossary -- BackmatterToday, quantum field theory (QFT)-the mathematical and conceptual framework for contemporary elementary particle physics-is the best starting point for analysing the fundamental building blocks of the material world. QFT if taken seriously in its metaphysical implications yields a picture of the world that is at variance with central classical conceptions. The core of Kuhlmann's investigation consists in the analysis of various ontological interpretations of QFT, e.g. substance ontologies as well as a process-ontological approach. Eventually, Kuhlmann proposes a dispositional trope ontology, aPhilosophische Analyse ;Bd. 37.OntologyPhysicsOntology.Physics.530.14530.143Kuhlmann Meinard1492836MiAaPQMiAaPQMiAaPQBOOK9910779735703321The ultimate constituents of the material world3725454UNINA04630nam 22006975 450 991030021440332120200701215654.03-319-17467-310.1007/978-3-319-17467-9(CKB)3710000000416808(EBL)2094728(SSID)ssj0001501430(PQKBManifestationID)11896721(PQKBTitleCode)TC0001501430(PQKBWorkID)11524765(PQKB)10739438(DE-He213)978-3-319-17467-9(MiAaPQ)EBC2094728(PPN)186026498(EXLCZ)99371000000041680820150527d2015 u| 0engur|n|---|||||txtccrDiagnosis and Management of Testicular Cancer The European Point of View /edited by Susanne Krege1st ed. 2015.Cham :Springer International Publishing :Imprint: Springer,2015.1 online resource (136 p.)Description based upon print version of record.3-319-17466-5 Includes bibliographical references.Part I: Overview of the latest recommendations of the European Germ Cell Cancer Group -- Part II: Special topics about controversial aspects, new results from studies, which might change treatment recommendations and long-term-survivorship: Is there still an indication for radiotherapy in seminoma CS I/ IIA/B?- How should we treat nonseminoma CSI? -- Is there still an indication for diagnostic RPLND in nonseminoma CSI? -- How could the prognosis of patients with intermediate risk disease be improved? -- How should patients with poor-prognosis disease be treated actually? -- How should patients with recurrent disease be treated actually? -- How important are prognostic factors for determining treatment in patients with primary or recurrent disease? -- What should be the boundaries in retroperitoneal residual tumor resection in nonseminoma? -- How should residual disease outside the retroperitoneum be treated? -- What are the recent recommendations for follow up in testicular cancer? -- What are the long-term toxicities to be controlled and treated? -- Consequences of the disease and its treatment concerning sexuality and fertility.This book presents the views of leading European experts on the diagnosis and management of testicular cancer, with coverage of current hot topics in the field. It opens by providing an overview of the recommendations in the most recent consensus paper from the European Germ Cell Cancer Consensus Group, which is based on interdisciplinary cooperation among urologists, medical oncologists, radio-oncologists, pathologists, and basic scientists. The remainder of the book focuses on areas of controversy in the diagnosis, treatment, and follow-up of testicular cancer. In each case the evidence base is discussed and results from the most recent studies are reviewed, drawing attention to new findings that might alter treatment recommendations. The treatment-related chapters cover a broad range of issues, including the best approach in patients with poor-prognosis and recurrent disease and those with long-term toxicities. Relevant aspects of survivorship care are also addressed. The book will help clinicians and practitioners to achieve the goals of minimizing therapy and its side-effects without reducing efficacy in low stage disease, improving the cure rate in advanced disease, and enhancing follow-up and long-term survivorship.OncologyUrologySurgeryRadiotherapyOncologyhttps://scigraph.springernature.com/ontologies/product-market-codes/H33160Urologyhttps://scigraph.springernature.com/ontologies/product-market-codes/H62002Surgeryhttps://scigraph.springernature.com/ontologies/product-market-codes/H59001Radiotherapyhttps://scigraph.springernature.com/ontologies/product-market-codes/H29056Oncology.Urology.Surgery.Radiotherapy.Oncology.Urology.Surgery.Radiotherapy.610615842616.6616994617Krege Susanneedthttp://id.loc.gov/vocabulary/relators/edtBOOK9910300214403321Diagnosis and Management of Testicular Cancer1761302UNINA